Jones Trading Reiterates Hold Rating on BioLineRx (BLRX)
Jones Trading analyst Justin Walsh reiterated a Hold rating on BioLineRx (NASDAQ: BLRX).The analyst comments "APHEXDA will provide a steady ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)